Login / Signup

The state of neuro-oncology during the COVID-19 pandemic: a worldwide assessment.

Maciej M MrugalaQuinn T OstromShelley M PressleyJennie W TaylorAlissa A ThomasJeffrey S WefelScott L CovenAlvina A AcquayeChas HaynesSameer AgnihotriMichael LimKatherine B PetersErik P SulmanJoanne T SalcidoNicholas A ButowskiShawn Hervey-JumperAlireza MansouriKathy R OliverAlyx B PorterFarshad NassiriDavid SchiffErin M DunbarMonika E HegiTerri S ArmstrongMartin J Van Den BentSusan M ChangGelareh ZadehMilan G Chheda
Published in: Neuro-oncology advances (2021)
The pandemic has changed treatment schedules and limited investigational treatment options. Institutional lack of support created clinician and researcher anxiety. Communication with patients was satisfactory. We make recommendations to guide clinical and scientific infrastructure moving forward and address the personal challenges of providers and researchers.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • sars cov
  • chronic kidney disease
  • prognostic factors
  • palliative care
  • randomized controlled trial
  • clinical trial
  • patient reported